May 2023 Provider News

Contents

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notices of material changes/amendments to contract - May 2023

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Moving Toward Equity in Asthma Care

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Looking to earn CME credits? Check out the CME Engagement Hub!

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Consolidated Appropriations Act: Review your online provider directory information regularly

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

You are invited! Skilled Nursing Facility (SNF) providers: Fall prevention and patient safety

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Submit corrected claims electronically for the Federal Employee Program®

Digital SolutionsAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Enhanced Provider News website and email communications launching May 1, 2023

Digital SolutionsAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Important information for providers registered to use Medical Attachments on Availity.com

Medical Policy & Clinical GuidelinesAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Medical Policy and Clinical Guideline updates

Reimbursement PoliciesAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Reimbursement policy update: Robotic Assisted Surgery – Professional

Reimbursement PoliciesAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Reimbursement policy update: Multiple and Bilateral Surgery Processing - Professional

PharmacyAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Clinical Criteria updates for specialty pharmacy

PharmacyAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Specialty pharmacy updates – May 2023

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

Genetic testing

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

Medical Policies and Clinical Utilization Management Guidelines update

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

You are invited! Skilled Nursing Facility (SNF) providers: Fall prevention and patient safety

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

Looking to earn CME credits? Check out the CME Engagement Hub!

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

Did your patient have a recent fracture?

MEBCBS-CRCM-023173-23

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

* Availity, LLC is an independent company providing administrative support services on behalf of the health plan.

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notices of material changes/amendments to contract - May 2023

Notices of material changes/amendments to contract may apply for new or updated reimbursement policies, medical policies, or prior authorization requirements. In this issue, please reference the following articles:

  • Medical Policy and Clinical Guideline updates
  • Reimbursement policy update: Multiple and Bilateral Surgery Processing – Professional
  • Specialty pharmacy updates
  • Reimbursement policy update: Technology Assisted Surgical Procedures – Professional and Facility
  • Clinical Criteria updates for specialty pharmacy
  • Transition to Carelon Medical Benefits Management, Inc. MRI Breast Clinical Appropriateness Guidelines

MEBCBS-CM-023114-23

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Moving Toward Equity in Asthma Care

Moving Toward Equity in Asthma Care CME Training and Asthma Medication Ratio HEDIS measure update

Moving Toward Equity in Asthma Care
Anthem Blue Cross and Blue Shield is committed to achieving health equity in asthma outcomes with diverse populations. As part of this commitment, we offer an online training, Moving Toward Equity in Asthma Care. This course is accessible from any mobile device or computer and provides one continuing medical education credit at no cost to you. Visit www.mydiversepatients.com.

 Asthma Medication Ratio (AMR) HEDIS® measure
The National Committee for Quality Assurance (NCQA) is also working to identify and reduce disparities in care. As part of this effort, race and ethnicity stratifications were added to the AMR HEDIS metric this year. The AMR metric measures the percentage of members 5 to 64 years of age who were identified as having persistent asthma and had a ratio of controller medications to total asthma medications of 0.5 or greater during the measurement year.

 Did you know: 

  • Hispanics and African Americans with asthma are less likely to take daily controllers and are more likely to visit the ER and be hospitalized for asthma-related conditions than non-Hispanic whites? 1
  • Asian Americans are more likely to die from asthma than non-Hispanic whites?2
  • Appropriate medication management for patients with asthma could reduce the need for rescue medication — as well as the costs associated with ER visits, inpatient admissions, and missed days of work or school?

 Helpful tips:  

  • Ensure at least half of the medications dispensed to treat asthma are controller medications throughout the measurement period. 
  • Talk to the patient about the importance of controller medication compliance, and not to use rescue medications on a regular basis, unless part of asthma action plan.
  • Encourage patients to fill their prescriptions on a regular schedule rather than waiting till they are symptomatic.
  • Create a written asthma action plan in language the patient understands, and schedule follow-up appointments with patients. Ask patients questions to assess asthma control, adherence to the action plan, and identify
  • Utilize evidence-based asthma assessment tools to assess asthma control, adherence to the action plan, and identify triggers.
  • Take the Moving Toward Equity in Asthma Care CME course at no cost for more helpful tips.

Additional resources
Also available is the Asthma & Me training. Do your patients have asthma? Show them the pathophysiology of asthma in their preferred language.

References:

  1. Asthma and Allergy Foundation of America & National Pharmaceutical Council. (2005). Ethnic Disparities in the Burden and Treatment of Asthma. Retrieved from http://www.aafa.org/media/Ethnic-Disparities-Burden-Treatment-Asthma-Report.pdf
  2. U.S. Department of Health & Human Service, Office of Minority Health. (2016, May 9). Asthma and Asian Americans. Retrieved August 8, 2016, from https://www.minorityhealth.hhs.gov
  3. Asthma and Allergy Foundation of America. (2020). Asthma Disparities in America: A Roadmap to Reducing Burden on Racial and Ethnic Minorities. Retrieved from: https://aafa.org/wp-content/uploads/2022/08/asthma-disparities-in-america-burden-on-racial-ethnic-minorities.pdf

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

MULTI-BCBS-CM-019268-23-CPN18979

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Looking to earn CME credits? Check out the CME Engagement Hub!

We’re committed to being actively involved with our care provider partners and going beyond the contract to create a real impact on the health of our communities. That’s why we offer care providers free continuing medical education (CME) sessions to learn best practices to overcoming barriers in achieving clinical quality goals and improved patient outcomes.

Engagement Hub objectives:

  • Learn strategies to help you and your care team improve your performance across a range of clinical areas.
  • Apply the knowledge you gain from the webinars to improve your organization’s clinical quality.
  • Offer care providers a convenient way to earn CME credits at a time that works best for you.

Register here for our free CME clinical quality webinars!

Note: Sessions in this series are approved for one American Academy of Family Physicians credit each.

MEBCBS-CM-023024-23-CPN22728

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Consolidated Appropriations Act: Review your online provider directory information regularly

Please review your online provider directory information on a regular basis to ensure it is correct. Access your online provider directory information by visiting anthem.com/provider, then under Provider Overview, select Find Care.

Submit updates and corrections to your directory information by using our online Provider Maintenance Form. Online update options include:

  • Add/change an address location
  • Name change
  • Provider leaving a group or a single location
  • Phone/fax number changes
  • Closing a practice location

Once you submit the form, we will send you an email acknowledging receipt of your request.

The Consolidated Appropriations Act (CAA) implemented in 2021 contains a provision that requires online provider directory information be reviewed and updated as needed at least every 90 days. By reviewing your information regularly, you help us ensure your online provider directory information is current.

MULTI-BCBS-CM-022695-23-CPN22692

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

You are invited! Skilled Nursing Facility (SNF) providers: Fall prevention and patient safety

Join this CME webinar to learn best practices to preventing falls of your older patients Wednesday, June 7, 2023 at noon EST.

Skilled Nursing Facility (SNF) providers: Fall prevention and patient safety

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Submit corrected claims electronically for the Federal Employee Program®

Providers can submit corrected claims for Federal Employee Program, (FEP), members using Availity Essentials* or through Electronic Data Interchange (EDI). The FEP member ID number start with the letter R, followed by eight numerical digits.

The corrected claims process begins when a claim has already been adjudicated. Multiple types of errors that occur can typically be corrected quickly with the options below. As a reminder, the corrected claim must be received within the timely filing.

Availity Essentials corrected claim submission

You can recreate a claim and submit it as a replacement or cancellation (void) of the original claim if Anthem has already accepted the original claim for processing. Follow these steps:

  • In the Availity Essentials menu, select Claims & Payments, and then select Professional Claim or Facility Claim, depending on which type of claim you want to correct.
  • Enter the claim information, and set the billing frequency and payer control number as follows:
    • Replacement of Prior Claim or Void/Cancel of Prior Claim.
    • Billing Frequency (or Frequency Type) field, in the Claim Information section (for professional and facility claims) or Ancillary Claim/Treatment Information section (for dental claims). Use 7 for replacement claims and 8 for voided claims.
    • Set the Payer Control Number (ICN / DCN) (or Payer Claim Control Number) field to the claim number assigned to the claim by Anthem. You can obtain this number from the 835 ERA or Remittance Inquiry on Payer Spaces.
  • Submit the claim.

EDI corrected claim submission

Corrected claims submitted electronically must also have the applicable frequency code and payer control number.

Frequency code:

  • For corrected professional (837P) claims, use one of the following frequency codes to indicate a correction was made to a previously submitted and adjudicated claim:
    • 7 — Replacement of prior claim\corrected claim
    • 8 — Void/cancel prior claim
  • For corrected institutional (837I) claims, use bill type frequency codes to indicate a correction was made to a previously submitted and adjudicated claim:
    • 0XX7 — Replacement of prior claim
    • 0XX8 — Void/cancel prior claim

Payer claim control number:

  • Use the original claim number assigned to the claim by Anthem.

Required EDI segments:

  • CLM05-3: Frequency Code (7,8)
  • REF: Payer Claim Control Number (original claim number)

Please confirm with your practice management software vendor and billing service or clearinghouse for full details and information on submitting corrected claims.

We encourage you and your staff to use the digital methods available to submit corrected claims to save costs in mailing, paper, and your valuable time.

* Availity, LLC is an independent company providing administrative support services on behalf of the health plan.

MULTI-BCBS-CM-022819-23

Digital SolutionsAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Enhanced Provider News website and email communications launching May 1, 2023

Effective May 1, 2023, we will enhance the Provider News website and email communications as part of our commitment to improving the way we do business with our provider community. Listening to your feedback, we are pleased to announce a new look and feel is coming to Provider News in the first half of 2023, with additional improvements planned throughout the rest of the year.

Stay tuned for more updates.

View the Quick Reference Guide for more information.

MEBCBS-CM-016122-22-CPN15788

Digital SolutionsAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Important information for providers registered to use Medical Attachments on Availity.com

Digital Request for Additional Information (Digital RFAI) is coming soon.
When your organization registered to use the Medical Attachments application through Availity Essentials,* you also registered to receive digital notifications through that application. This makes it possible for Anthem Blue Cross and Blue Shield (Anthem) to notify you digitally when we need documents to process your claim.

Beginning June 1, 2023, Anthem will notify you through your Attachments Dashboard when we need medical records, itemized bills, or other documents required to process our Commercial member claims. You will no longer receive a paper letter or remittance advice when we need documents to process most claims.

Enabling more efficient processes
Each morning, you will receive Digital RFAI notifications in your Attachments Dashboard Inbox for claims we are unable to process because we need supporting documentation. For certain claim types, we will pend the claim, rather than deny. You will have 30 days from the notification to digitally submit the needed attachments.

If we don’t receive the needed attachments within 30 days, the claim will then deny, and you will receive a remittance advice. An additional notification will be posted to your Attachments Dashboard Inbox for up to 45 days to allow you to attach the documents to the notification.

How to prepare to receive digital notifications:

  • Check your Medical Attachments application registration:
    • If you are already registered to use the Medical Attachments application, make sure all your billing NPIs are correctly registered.
    • Ask your Availity administrator to verify your registration.
    • Use the self-service learning module to help your Availity administrator check your registration.
  • Check your staff’s security:
    • All team members needing access to attachment information should have these role assignments:
      • Claims Status
      • Medical Attachments
    • Ask your Availity administrator to confirm all the role assignments are correctly applied to the right team members. They need to have access to the organization ID (customer ID) for which the billing NPIs are registered.
    • Use the self-service learning module to help your Availity administrator check your team members role assignments.

Help, training, and support
In collaboration with Availity, we’ve developed training for your organization’s administrators about how to update the Medical Attachment registration:

DateStart Time
April 24, 20232 p.m. Eastern time
April 28, 20232 p.m. Eastern time
May 10, 20232 p.m. Eastern time

Availity administrators can use this link to register for live training or to view the live training.

For associates who are responsible for sending attachments, we’ve developed an enhanced training session that walks through the Attachments Dashboard and many of the unique features that make it most efficient:

DateStart Time
May 11, 20232:30 p.m. Eastern time
May 12, 202311 a.m. Eastern time
May 15, 202311 a.m. Eastern time

Availity users with the Medical Attachments and Claims Status role assignment can use this link to register for live training or to view the live training.

Through this efficient process, we are receiving needed support documentation 50% faster than through the outdated method of mailing letters and receiving attachments through non-digital methods.1 If you are using the PWK process to submit attachments, you may still receive Digital RFAI notifications in your dashboard, if:

  • You didn’t send us the correct document.
  • We need additional documents.
  • The PWK attachment wasn’t received within seven days.

Resources available
Use the helpful resources for information that can help for a smooth transition to Digital RFAI notifications:

For additional resources, call Availity Client Services at 800-282-4548.

1 Source: Internal Digital RFAI provider satisfaction survey

* Availity, LLC is an independent company providing administrative support services on behalf of the health plan.

MULTI-BCBS-CM-023002-23-CPN22936

Medical Policy & Clinical GuidelinesAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Medical Policy and Clinical Guideline updates

The following new and revised Medical Policies and Clinical Guidelines were endorsed at the February 16, 2023, Medical Policy & Technology Assessment Committee (MPTAC) meeting. These, and all of Anthem Blue Cross and Blue Shield’s Medical Policies and Clinical Guidelines, are available at anthem.com. Select ForProviders. Under the Provider Resources heading, select Policies, Guidelines & Manuals. Select your state. Then, select View Medical Policies & Clinical UM Guidelines.

To view Medical Policies and Clinical Utilization Management Guidelines applicable to members enrolled in the Blue Cross and Blue Shield Service Benefit Plan (commonly referred to as the Federal Employee Program® [FEP]), visit fepblue.org > Policies & Guidelines

Medical Policy updates

New Medical Policy effective August 1, 2023

The following policy is new:

  • MED.00145 Digital Therapy Devices for Treatment of Amblyopia*

Revised Medical Policies effective August 1, 2023

The policies below were revised and might result in services that were previously covered but may now be found to be either not medically necessary and/or investigational:

  • MED.00101 Physiologic Recording of Tremor using Accelerometer(s) and Gyroscope(s)*
  • SURG.00158 Implantable Peripheral Nerve Stimulation Devices as a Treatment for Pain*

Clinical Guideline updates

Revised Clinical Guideline effective August 1, 2023

The following adopted guideline was revised and might result in services that were previously covered but may now be found to be not medically necessary:

  • CG-MED-73 Hyperbaric Oxygen Therapy (Systemic/Topical)*

* The applicable policy is attached to this article in PDF format.

MEBCBS-CM-022605-23

ATTACHMENTS (available on web): CG-MED-73_Pub 04-12-2023.pdf (pdf - 0.42mb) MED.00101_Pub 04-12-2023.pdf (pdf - 0.49mb) MED.00145_Pub 04-12-2023.pdf (pdf - 0.44mb) SURG.00158_Pub 03-29-2023.pdf (pdf - 0.48mb)

Reimbursement PoliciesAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Reimbursement policy update: Robotic Assisted Surgery – Professional

Beginning with dates of service on or after August 1, 2023, Anthem Blue Cross and Blue Shield’s Robotic Assisted Surgery – Professional reimbursement policy will expand to include CPT® codes for computer-assisted surgical systems.

This policy does not allow separate reimbursement for technology assisted services detailed in the Related Coding section. These services are considered integral to the primary surgical procedure, are included in the primary surgical procedure, and are not separately reimbursed.

The Related Coding section of the policy has been updated to include the following computer assisted surgical musculoskeletal navigation procedures:

  • 0054T: Computer-assisted musculoskeletal surgical navigational orthopedic procedure, with image-guidance based on fluoroscopic images (List separately in addition to code for primary procedure)
  • 0055T: Computer-assisted musculoskeletal surgical navigational orthopedic procedure, with image-guidance based on CT/MRI images (List separately in addition to code for primary procedure)
  • 20985: Computer-assisted surgical navigational procedure for musculoskeletal procedures, image-less (List separately in addition to code for primary procedure)

The policy has been renamed to Technology Assisted Surgical ProceduresProfessional and Facility, which defines both robotic assisted and computer assisted techniques.

For specific policy details, visit the reimbursement policy page at Anthem.com.

MULTI-BCBS-CM-022961-23-CPN22785

ATTACHMENTS (available on web): Technology Asst Surgery.pdf (pdf - 0.15mb)

Reimbursement PoliciesAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Reimbursement policy update: Multiple and Bilateral Surgery Processing - Professional

Beginning with dates of service on or after August 1, 2023, Anthem Blue Cross and Blue Shield’s Multiple and Bilateral Surgery Processing Professional reimbursement policy will be updated to include two new CPT® codes for the Esophagogastroduodenoscopy (EGD) code family.

This policy allows reimbursement for multiple and bilateral procedures. Reimbursement is based on Centers of Medicare & Medicaid (CMS) standard multiple and bilateral procedure rules for multiple arthroscopic and endoscopic surgical procedures.

The Related Coding section has been updated to include the following new CPT codes released by CMS for the Esophagogastroduodenoscopy (EGD) code family:

  • 43290 — Esophagogastroduodenoscopy, flexible, transoral; with deployment of intragastric bariatric balloon:
    • Added CPT code 43290 to base code 43235 Esophagogastroduodenoscopy (EGD) with the reduction of 100% primary and 25% subsequent
  • 43291 — Esophagogastroduodenoscopy, flexible, transoral; with removal of intragastric bariatric balloon(s):
    • Added CPT code 43291 to base code 43235 Esophagogastroduodenoscopy (EGD) with the reduction of 100% primary and 25% subsequent

For specific policy details, visit the reimbursement policy page at anthem.com.

MULTI-BCBS-CM-022967-23-CPN22812

ATTACHMENTS (available on web): Multiple and Bilateral Surgery.pdf (pdf - 0.2mb)

PharmacyAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Clinical Criteria updates for specialty pharmacy

The following Clinical Criteria documents were endorsed at the February 24, 2023, Clinical Criteria meeting. Visit our website to access the Clinical Criteria information.

New Clinical Criteria effective August 1, 2023

The following Clinical Criteria are new:

  • CC-0230 Adstiladrin (nadofaragene firadenovec-vncg)*
  • CC-0233 Rebyota (fecal microbiota, live – jslm)*

Revised Clinical Criteria effective August 1, 2023

The following Clinical Criteria were revised and might result in services that were previously covered but may now be found to be not medically necessary:

  • CC-0062 Tumor Necrosis Factor Antagonists*
  • CC-0086 Spravato (esketamine) Nasal Spray*
  • CC-0096 Asparagine Specific Enzymes*
  • CC-0110 Perjeta (pertuzumab)*
  • CC-0115 Kadcyla (ado-trastuzumab)*
  • CC-0116 Bendamustine agents*
  • CC-0119 Yervoy (ipilimumab)*
  • CC-0120 Kyprolis (carfilzomib)*
  • CC-0128 Tecentriq (atezolizumab)*
  • CC-0158 Enhertu (fam-trastuzumab deruxtecan-nxki)*

PharmacyAnthem Blue Cross and Blue Shield | CommercialMay 1, 2023

Notice of material change/amendment to contract

Specialty pharmacy updates – May 2023

Specialty pharmacy updates for Anthem Blue Cross and Blue Shield (Anthem) are listed below.

Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by the Anthem Medical Specialty Drug Review Team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company.

Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications.

Including the National Drug Code (NDC) code on your claim may help expedite claim processing of drugs billed with a not otherwise classified (NOC) code.

Prior authorization updates

Effective for dates of service on and after August 1, 2023, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process.

Access our Clinical Criteria to view the complete information for these site of prior authorization updates.

Clinical Criteria

Drug

HCPCS or CPT® code(s)

CC-0230

Adstiladrin (nadofaragene firadenovec-vncg)

J9999

CC-0062

Idacio (adalimumab-aacf)

J3490, J3590

CC-0231

Lamzede (velmanase alfa-tycv)

C9399, J3490

CC-0232*

Lunsumio (mosunetuzumab-axgb)

C9399, J3490, J3590, J9999

CC-0233

Rebyota (fecal microbiota, live – jslm)

C9399, J3490, J3590

CC-0234

Syfovre (pegcetacoplan)

C9399, J3490

CC-0116*

Vivimusta (bendamustine)

J9999

* Oncology use is managed by Carelon Medical Benefits Management, Inc.

Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.

Site of care updates

Effective for dates of service on and after August 1, 2023, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our site of care review process.

Access our Clinical Criteria to view the complete information for these site of care updates.

Clinical Criteria

Drug

HCPCS or CPT code(s)

CC-0217

Amvuttra (vutrisiran)

J0225

CC-0194

Cabenuva (cabotegravir extended-release; rilpivirine extended-release)

J0741

CC-0003

Cutaquig (immune globulin)

J1551

CC-0210

Enjaymo (sutimlimab-jome)

J1302

CC-0018

Nexviazyme (avalglucosidase alfa-ngpt)

J0219

CC-0019

Reclast (zoledronic acid)

J3489

CC-0075

Riabni (rituximab-arrx)

Q5123

CC-0075

Ruxience (rituximab-pvvr)

Q5119

CC-0202

Saphnelo (anifrolumab-fnia)

J0491

CC-0212

Tezspire (tezepelumab-ekko)

J2356

CC-0075

Truxima (rituximab-abbs)

Q5115

CC-0207

Vyvgart (efgartigimod alfa-fcab)

J9332

CC-0220

Xenpozyme (olipudase alfa)

J0218

Effective for dates of service on and after August 1, 2023, the following specialty pharmacy codes from current or new Clinical Criteria documents will be removed from our site of care review process.

Clinical Criteria

Drug

HCPCS or CPT code(s)

CC-0004

Acthar (corticotropin)

J0800

CC-0034

Berinert (C1 Esterase Inhibitor, Human)

J0597

CC-0034

Firazyr (icatibant)

J1744

CC-0154

Givlaari (givosiran)

J0223

CC-0034

Kalbitor (ecallantide)

J1290

CC-0013

Mepsevii (vestronidase alfa)

J3397

CC-0073

Prolastin-C (alpha-1 proteinase inhibitor)

J0256

CC-0156

Reblozyl (luspatercept)

J0896

CC-0034

Ruconest (C1 Esterase Inhibitor, Recombinant)

J0596

Quantity limit updates

Effective for dates of service on and after August 1, 2023, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process.

Access our Clinical Criteria to view the complete information for these quantity limit updates.

Clinical Criteria

Drug

HCPCS or CPT code(s)

CC-0230

Adstiladrin (nadofaragene firadenovec-vncg)

J9999

CC-0062

Idacio (adalimumab-aacf)

J3490, J3590

CC-0231

Lamzede (velmanase alfa-tycv)

C9399, J3490

CC-0233

Rebyota (fecal microbiota, live – jslm)

C9399, J3490, J3590

CC-0234

Syfovre (pegcetacoplan)

C9399, J3490

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

Genetic testing

For professional claims submitted on a CMS-1500 form processed on or after June 1, 2023, Anthem Blue Cross and Blue Shield will enhance our editing systems to automate edits and simplify remittance messaging. These edit enhancements are supported by correct coding guidelines as documented in industry sources such as Correct Procedural Terminology (CPT®) guidelines and Centers for Medicare & Medicaid Services (CMS). Additionally, these edit enhancements will promote faster claim processing and reduce follow-up audits and/or record requests for claims that are not consistent with correct coding guidelines. As a result of these edit enhancements, there will be greater attention on identifying inappropriate billing of genetic testing services.

Below are examples of claim edits focused on identifying inappropriate billing of genetic testing services that will be automated:

  • Multianalyte Assays with Algorithmic Analyses (MAAA) — CPT 81507: This edit will deny laboratory provider claims submitted with the proprietary laboratory analysis code for the associated proprietary harmony prenatal test when the laboratory provider is not an affiliated proprietary laboratory.
  • Panel testing: This edit will deny laboratory provider claims submitted with codes for individual components of a panel test (for example, tumors, inherited conditions, and hematologic malignancy) when a single panel code exists.
    Providers who believe their medical record documentation supports services billed should follow the claims payment dispute process (including submission of all supporting documentation with the dispute) as outlined in the provider manual.

If you have questions on this program, contact your Provider Relationship Account Manager.

MULTI-BCBS-CR-019035-23-CPN18337

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

Medical Policies and Clinical Utilization Management Guidelines update

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised to support clinical coding edits. Note, several policies and guidelines were revised to provide clarification only and are not included. Existing precertification requirements have not changed. 

Please share this notice with other providers in your practice and office staff.

To view a guideline, visit https://www.anthem.com/provider/policies/clinical-guidelines.

Notes/updates

Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive:

  • CG-DME-31 - Powered Wheeled Mobility Devices:
    • Added Not Medically Necessary statement for powered wheeled mobility devices using computerized systems to assist with functions such as seat elevation and navigation over curbs, stairs, or uneven terrain (for example, the iBOT Personal Mobility Device) for all indications
  • CG-LAB-24 - Outpatient Urine Culture:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for outpatient urine culture testing for bacteria
  • CG-LAB-25 - Outpatient Glycated Hemoglobin and Protein Testing:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for outpatient glycated hemoglobin (HbA1c) and total glycated serum proteins (GSPs) testing
  • CG-MED-92 - Foot Care Services:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for foot care services
  • CG-MED-93 - Navigational Bronchoscopy:
    • Moved content from MED.00099 Navigational Bronchoscopy to a new clinical UM guideline document with the same title
    • Added Medically Necessary criteria for navigational bronchoscopy
    • Revised Investigational & Not Medically Necessary statement to Not Medically Necessary when criteria not met
  • CG-SURG-115 - Mechanical Embolectomy for Treatment of Stroke:
    • Moved content from SURG.00098 Mechanical Embolectomy for Treatment of Acute Stroke to new clinical UM guideline document with a similar title
    • Investigational & Not Medically Necessary changed to Not Medically Necessary as a result of MP to CUMG transition
  • CG-SURG-116 - Surgical Treatment of Hyperhidrosis:
    • Moved content from CG-MED-63 Treatment of Hyperhidrosis to new clinical UM guideline document
    • Change of category and addition of surgical to title
    • Moved content related to iontophoresis to CG-MED-28 Iontophoresis
  • GENE.00052 - Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling:
    • Moved content from GENE.00037 Genetic Testing for Macular Degeneration and CG-GENE-23 Genetic Testing for Heritable Cardiac Conditions into this document
    • Added chromosome conformation signatures to scope of document and Investigational & Not Medically Necessary statement
  • MED.00130 - Surface Electromyography and Electrodermal Activity Sensor Devices for Seizure Monitoring; Previously titled: Surface Electromyography Devices for Seizure Monitoring:
    • Revised title
    • Revised Position Statement by adding electrodermal activity sensor devices
  • MED.00135 - Gene Therapy for Hemophilia:
    • Outlines the Medically Necessary and Investigational & Not Medically Necessary criteria for a one-time infusion of etranacogene dezaparvovec-drlb for select individuals with hemophilia B
  • MED.00143 - Ingestible Devices for the Treatment of Constipation:
    • Outlines the Investigational & Not Medically Necessary criteria for Ingestible devices for the treatment of constipation
  • SURG.00097 - Scoliosis Surgery:
    • Added magnetically controlled growing rods to scope of document in Investigational & Not Medically Necessary statement

Medical Policies

On November 10, 2022, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to AMH Health, LLC. These guidelines take effect April 30, 2023.

Publish date

Medical Policy #

Medical Policy title

New or revised

12/28/2022

*GENE.00052

Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling

Revised

1/4/2023

*MED.00130

Surface Electromyography and Electrodermal Activity Sensor Devices for Seizure Monitoring

Previously titled: Surface Electromyography Devices for Seizure Monitoring

Revised

12/6/2022

*MED.00135

Gene Therapy for Hemophilia

New

1/4/2023

*MED.00143

Ingestible Devices for the Treatment of Constipation

New

1/4/2023

*SURG.00097

Scoliosis Surgery

Revised

1/4/2023

TRANS.00029

Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias

Revised

Clinical UM Guidelines

On November 10, 2022, the MPTAC approved the following Clinical UM Guidelines applicable to AMH Health. These guidelines were adopted by the medical operations committee for AMH Health members on December 15, 2022. These guidelines take effect April 30, 2023.

Publish date

Clinical UM Guideline #

Clinical UM Guideline title

New or revised

1/4/2023

*CG-DME-31

Powered Wheeled Mobility Devices

Revised

11/17/2022

CG-DME-44

Electric Tumor Treatment Field (TTF)

Revised

1/4/2023

*CG-LAB-24

Outpatient Urine Culture

New

1/4/2023

*CG-LAB-25

Outpatient Glycated Hemoglobin and Protein Testing

New

1/4/2023

*CG-MED-92

Foot Care Services

New

1/4/2023

CG-MED-93

Navigational Bronchoscopy

Conversion New

1/4/2023

CG-SURG-115

Mechanical Embolectomy for Treatment of Stroke

Conversion New

11/17/2022

CG-SURG-116

Surgical Treatment of Hyperhidrosis

Conversion New

MEAMH-CR-017741-23-CPN17228

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

Update: Authorizations for DMEPOS services for Medicare Advantage Individual, Group Retiree Solutions, and Dual-Eligible plan members

The fax number on the previous communication was incorrect and has been corrected here. The correct fax number is 833-678-0223.

For services beginning on July 1, 2023, prior authorization requests for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) services will be reviewed by Carelon Post Acute Solutions, LLC.* The goal of this program is to ensure members receive the right product for the right duration of time in the home. This change will be applicable to the following markets: Maine.

How to submit or check a prior authorization request

For DMEPOS services, Carelon Post Acute Solutions will begin receiving requests on Tuesday, June 20, 2023, for dates of service July 1, 2023, and after.  

Providers are encouraged to request authorization using the website. Go here to get started. You can upload clinical information and check the status of your requests through this online tool seven days a week, 24 hours a day. If you are unable to use the link or website, you can call the Carelon Post Acute Solutions Provider Call Center at 844-411-9622 during normal operating hours from 7 a.m. to 7 p.m. CT, Monday through Friday, or send a fax to Carelon Post Acute Solutions at 833-678-0223.

Please note: Carelon Post Acute Solutions will not review authorization requests for products/services that do not fall under Medicare-covered products/services, such as home infusion, hospice, outpatient therapy, or supplemental benefits that help with everyday health and living such as personal home helper services offered under Essential/Everyday Extras.

To learn more about Carelon Post Acute Solutions and upcoming training webinars, visit the website or email.

If you have additional questions, please call the Carelon Post Acute Solutions Provider Call Center at 844-411-9622.

* Carelon Post Acute Solutions, LLC is an independent company providing services on behalf of the health plan.

MEAMH-CR-024045-23-CPN24014

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

You are invited! Skilled Nursing Facility (SNF) providers: Fall prevention and patient safety

Join this CME webinar to learn best practices to preventing falls of your older patients Wednesday, June 7, 2023 at noon EST.

Skilled Nursing Facility (SNF) providers: Fall prevention and patient safety

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

Looking to earn CME credits? Check out the CME Engagement Hub!

We’re committed to being actively involved with our care provider partners and going beyond the contract to create a real impact on the health of our communities. That’s why we offer care providers free continuing medical education (CME) sessions to learn best practices to overcoming barriers in achieving clinical quality goals and improved patient outcomes.

Engagement Hub objectives:

  • Learn strategies to help you and your care team improve your performance across a range of clinical areas.
  • Apply the knowledge you gain from the webinars to improve your organization’s clinical quality.
  • Offer care providers a convenient way to earn CME credits at a time that works best for you.

Register here for our free CME clinical quality webinars!

Note: Sessions in this series are approved for one American Academy of Family Physicians credit each.

MEAMH-CR-023023-23

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMay 1, 2023

Did your patient have a recent fracture?

Who is affected

For women ages 67 to 85 who sustained a recent fracture, it is important to obtain a bone density scan to assess for osteoporosis.

How can we collaborate?

We can help your patients complete this scan in the comfort of their home through Quest Health Connect.

In home resources

We are working with Quest HealthConnect™, a Quest Diagnostics service, to provide this service at no added cost to you. Quest HealthConnect will call your patient to arrange a visit. Patients may also call them directly at 888-306-0615 between 8:30 a.m. to 4 p.m. Eastern Time. The result(s) of the screening test(s) will be sent to both the patient and your office after the visit.

* Quest Diagnostics is an independent company providing preventive care technology and health risk assessments services on behalf of the health plan.

MEAMH-CR-017875-23-CPN17332